tiprankstipranks
Advertisement
Advertisement

INO Stock Latest News

Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
The FlyInovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
2d ago
INO
Inovio Shareholders Endorse Governance Changes and Leadership
PremiumCompany Announcements
Inovio Shareholders Endorse Governance Changes and Leadership
3d ago
8K
INO
Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze
PremiumCompany Announcements
Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze
4d ago
INO
Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain
PremiumCompany Announcements
Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain
9d ago
INO
Inovio reports Q1 EPS (28c), consensus (33c)
PremiumThe Fly
Inovio reports Q1 EPS (28c), consensus (33c)
10d ago
INO
Inovio options imply 15.1% move in share price post-earnings
PremiumThe FlyInovio options imply 15.1% move in share price post-earnings
10d ago
INO
Options Volatility and Implied Earnings Moves Today, May 13, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 13, 2026
10d ago
TM
INO
Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
12d ago
B
BN
Is INO a Buy, Before Earnings?
PremiumPre-Earnings
Is INO a Buy, Before Earnings?
12d ago
INO
Inovio Pharmaceuticals Announces New Public Equity Offering
PremiumCompany Announcements
Inovio Pharmaceuticals Announces New Public Equity Offering
2M ago
8K
INO
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
PremiumCompany Announcements
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
2M ago
8K
INO
Inovio files to sell common stock, no amount given
PremiumThe Fly
Inovio files to sell common stock, no amount given
2M ago
INO
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
PremiumMarket NewsShareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
2M ago
INO
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
Premium
Company Announcements
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
2M ago
INO
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
Premium
Ratings
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
2M ago
INO
Inovio reports Q4 EPS (26c), consensus (34c)
PremiumThe Fly
Inovio reports Q4 EPS (26c), consensus (34c)
2M ago
INO
Options Volatility and Implied Earnings Moves Today, March 12, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 12, 2026
2M ago
S
DG
Inovio, Akeso announce clinical collaboration
PremiumThe Fly
Inovio, Akeso announce clinical collaboration
3M ago
INO
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
PremiumClass Action
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
3M ago
INO
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsINO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
INO
Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop
Premium
Class Action
Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop
3M ago
INO
LEVI & KORSINSKY, LLP: CELLECTRA DEVICE MANUFACTURING PRACTICES AT CENTER OF INOVIO PHARMACEUTICALS SECURITIES LITIGATION
Premium
Class Action
LEVI & KORSINSKY, LLP: CELLECTRA DEVICE MANUFACTURING PRACTICES AT CENTER OF INOVIO PHARMACEUTICALS SECURITIES LITIGATION
3M ago
INO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >